Last updated: 11/07/2018 06:07:01
A Single-Center, Randomized, Phase 0 Study to Investigate the Effectiveness, Safety and Tolerability of Two Inflammatory Pain Models, Tape Stripping and Imiquimod Cream Challenge, in Healthy Male Subjects
GSK study ID
113437
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A Single-Center, Randomized, Phase 0 Study to Investigate the Effectiveness, Safety and Tolerability of Two Inflammatory Pain Models, Tape Stripping and Imiquimod Cream Challenge, in Healthy Male Subjects
Trial description: A Single-Center, Randomized, Phase 0 Study to Investigate the Effectiveness, Safety and Tolerability of Two Inflammatory Pain Models, Tape Stripping and Imiquimod Cream Challenge, in Healthy Male Subjects
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Marion C. Dickson, Valerie J. Ludbrook, Hayley C. Perry, Paul A. Wilson, Sam J. Garthside, Michael H. Binks.A model of skin inflammation in humans leads to a rapid and reproducible increase in the interferon response signature: a potential translational model for drug development.Inflamm Res.2015;64(3):171-183
Medical condition
Inflammation
Product
Not applicable
Collaborators
Not applicable
Study date(s)
February 2010 to April 2010
Type
Not applicable
Phase
Not applicable
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
No study documents available.
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2010-15-04
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website